Incidence of nephrotoxicity in critically ill patients receiving intravenous colistin

被引：0
|
作者：
Alexander, Earliest [1 ]
Koshaish, Jena [1 ]
Glass, Maresa D. [1 ]
机构：
[1] Tampa Gen Hosp, Tampa, FL 33606 USA
来源：
CRITICAL CARE MEDICINE | 2007年 / 35卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1018
引用
收藏
页码：A283 / A283
页数：1
相关论文
共 50 条
  • [1] Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients
    Doshi, Neha M.
    Mount, Kari L.
    Murphy, Claire V.
    [J]. PHARMACOTHERAPY, 2011, 31 (12): : 1257 - 1264
  • [2] NEPHROTOXICITY ASSOCIATED WITH INTRAVENOUS COLISTIN IN CRITICALLY ILL PATIENTS
    Doshi, Neha
    Mount, Kari
    Murphy, Claire
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (12) : U240 - U240
  • [3] Incidence of intravenous colistin nephrotoxicity in hospitalized patients
    Espinoza, Cristian Rosas
    Caro Teller, Jose Manuel
    de la Calle, Guillermo Maestro
    Loitegui, Maria Arrieta
    Ferrari Piquero, Jose Miguel
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (01) : 12 - 17
  • [4] Incidence of nephrotoxicity in critically ill patients receiving tobramycin versus a control group
    Varnado, Sara
    Ali, Naeem
    Doepker, Bruce
    Ryder, Lindsay
    Phillips, Gary
    Mount, Kari
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [5] Dosing Guidance for Intravenous Colistin in Critically Ill Patients
    Nation, Roger L.
    Garonzik, Samira M.
    Thamlikitkul, Visanu
    Giamarellos-Bourboulis, Evangelos J.
    Forrest, Alan
    Paterson, David L.
    Li, Jian
    Silveira, Fernanda P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 64 (05) : 565 - 571
  • [6] Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration
    Karvanen, Matti
    Plachouras, Diamantis
    Friberg, Lena E.
    Paramythiotou, Elisabeth
    Papadomichelakis, Evangelos
    Karaiskos, Ilias
    Tsangaris, Iraklis
    Armaganidis, Apostolos
    Cars, Otto
    Giamarellou, Helen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 668 - 671
  • [7] Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy
    Ozel, Ayse Serra
    Ergonul, Onder
    Korten, Volkan
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2019, 13 (10): : 877 - 885
  • [8] Risk factors for colistin-associated nephrotoxicity and mortality in critically ill patients
    Ozkarakas, Huseyin
    Kose, Isil
    Zincircioglu, Ciler
    Ersan, Sibel
    Ersan, Gursel
    Senoglu, Nimet
    Kose, Sukran
    Erbay, Riza Hakan
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (04) : 1165 - 1172
  • [9] Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
    Gauthier, Timothy P.
    Wolowich, William R.
    Reddy, Arathi
    Cano, Ennie
    Abbo, Lilian
    Smith, Laura B.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2392 - 2396
  • [10] Colistin in critically ill patients
    Boisson, M.
    Gregoire, N.
    Couet, W.
    Mimoz, O.
    [J]. MINERVA ANESTESIOLOGICA, 2013, 79 (02) : 200 - 208
12345